3D Printed Personalized Extendable Prosthesis

Sponsor
Yuxi Su (Other)
Overall Status
Completed
CT.gov ID
NCT05794594
Collaborator
(none)
25
1
89
0.3

Study Details

Study Description

Brief Summary

The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is:

Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma?

Condition or Disease Intervention/Treatment Phase
  • Device: 3D printed personalized extendable prosthesis

Detailed Description

Osteosarcoma is one of the most common primary malignant bone tumors in children and adolescents. In this study, the investigators try to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma.

Study Design

Study Type:
Observational
Actual Enrollment :
25 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
3D Printed Personalized Extendable Prosthesis Replacement for Limb Preservation in Children With Osteosarcoma: a Preliminary Study
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
Jan 1, 2023
Actual Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
3D printed

3D printed personalized extendable prosthesis replacement for limb preservation in children with osteosarcoma

Device: 3D printed personalized extendable prosthesis
3D printed personalized extendable prosthesis replacement for limb preservation in children

amputation

patients had undergone amputation of the limbs

Outcome Measures

Primary Outcome Measures

  1. Recurrence [7years]

    Osteosarcoma recurrence rate

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • tumors of the extremities, with moderate soft-tissue invasion

  • the neurovascular bundle is not invaded, and the tumor can be excised totally

  • no metastatic lesions or metastases can be cured

Exclusion Criteria:
  • recurrent tumors

  • poorly differentiated tumors

  • poor soft-tissue conditions

  • neurovascular invasion around tumors

  • ineffective chemotherapy with metastasis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital of Chongqing Medical University Chongqing Chongqing China 400014

Sponsors and Collaborators

  • Yuxi Su

Investigators

  • Principal Investigator: Yuxi Su, Children's Hospital of Chongqing Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yuxi Su, Children's Hospital of Chongqing Medical University, Children's Hospital of Chongqing Medical University
ClinicalTrials.gov Identifier:
NCT05794594
Other Study ID Numbers:
  • CHChongqingMU-2
First Posted:
Apr 3, 2023
Last Update Posted:
Apr 3, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 3, 2023